The new policy goes into effect in November, improving Medicare coverage for a technology that has rapidly gained momentum in recent years.

Some 60% of IT professionals and 51% of operational leaders admit they’re reluctant to involve clinicians in software decisions. 

The popular AI chatbot tends to over-order X-rays, prescribe too many antibiotics and admit too many patients to the hospital when compared with a resident emergency department physician. 

The FDA clearly sees significant potential in this new screening software from New York-based AccurKardia.

As 2024 winds down and the number of FDA-approved medical devices packing AI approaches 1,000—the agency had the tally at 950 as of August—the industry finds itself at a “critical inflection point.” 

Nurses tend to feel optimistic if not exactly excited about AI’s advances into their profession. Those who hold back tend to share a common concern—sacrificing care quality for the sake of tech-enabled efficiency. 

Generative AI is fixing to transform the pharmaceutical industry. However, not all adopters will reap rewards in comparable degrees.  

10 notable quotes about AI from the past 5 days.